A Randomised Controlled Trial Comparing Topical Glycerol versus Narrow Band Ultraviolet Light B in Atopic Dermatitis: A Clinical and Bacteriological Evaluation - Trial PACTR201810815694251
Access comprehensive clinical trial information for PACTR201810815694251 through Pure Global AI's free database. This Not Applicable trial is sponsored by Cairo University and is currently Completed. The study focuses on Skin and Connective Tissue Diseases.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Cairo University
Self funded by investigator
Timeline & Enrollment
Not Applicable
Jan 01, 1900
Jan 01, 1900
Summary
Background: Atopic dermatitis (AD) is a chronic allergic disorder whose treatment is still a challenge. The staphylococcal skin load has been previously shown to aggravate AD. Narrow band ultraviolet B (NB-UVB) and glycerol in low concentration (20-40%) are established therapies for AD. Narrow band-UVB has been clinically proven to have antimicrobial actions and high concentration glycerol (85-100%) has been proven in vitro to have similar effects but hasn’t been clinically tested.Objectives: To evaluate the efficacy and tolerability of glycerol (85%) compared to NB-UVB in patients with atopic dermatitis, as assessed by clinical improvement and reduction of staphylococcal colonization of the skin.
ICD-10 Classifications
Data Source
Pan Africa Clinical Trials Registry
PACTR201810815694251
Non-Device Trial